Skip to main content
logo
Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
9.85
+0.07 (0.72%)
At close: Dec 5, 2025, 4:00 PM EST
9.89
+0.04 (0.41%)
After-hours: Dec 5, 2025, 7:34 PM EST

Revenue by Product

Millions AUD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Precision Medicine
771.11M
Log In
Log In
Log In
Log In
Upgrade
Therapeutics
9.35M
Log In
Log In
Log In
Log In
Upgrade
Manufacturing Solutions
2.75M
Log In
Log In
Log In
Log In
Upgrade
Commercial
-
Log In
Log In
Log In
Log In
Upgrade
Commercial Growth
-
Log In
Log In
Log In
Log In
Upgrade
Product Development
-
Log In
Log In
Log In
Log In
Upgrade
Product Development Growth
-
Log In
Log In
Log In
Log In
Upgrade
Molecularly Targeted Radiation
-
Log In
Log In
Log In
Log In
Upgrade
Molecularly Targeted Radiation Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions AUD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
United States
762.31M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
55.68%
Log In
Log In
Log In
Log In
Upgrade
Other Countries
16.01M
Log In
Log In
Log In
Log In
Upgrade
Other Countries Growth
242.94%
Log In
Log In
Log In
Log In
Upgrade
Canada
2.54M
Log In
Log In
Log In
Log In
Upgrade
Australia
1.22M
Log In
Log In
Log In
Log In
Upgrade
Australia Growth
4.63%
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
579.00K
Log In
Log In
Log In
Log In
Upgrade
United Kingdom Growth
-55.67%
Log In
Log In
Log In
Log In
Upgrade
Belgium
546.00K
Log In
Log In
Log In
Log In
Upgrade
Belgium Growth
19.21%
Log In
Log In
Log In
Log In
Upgrade
China
-
Log In
Log In
Log In
Log In
Upgrade
China Growth
-
Log In
Log In
Log In
Log In
Upgrade
Austria
-
Log In
Log In
Log In
Log In
Upgrade
Australia, United States, Belgium and Japan
-
Log In
Log In
Log In
Log In
Upgrade
Australia, United States, Belgium and Japan Growth
-
Log In
Log In
Log In
Log In
Upgrade